« Introgen Receives Notification from Nasdaq (Centre Daily Times) Introgen Therapeutics, | Main | FDA Approves Treatment for Rare Neurologic Disease The U.S. Food »

FDA Issues Interim Safety and Risk Assessment of Melamine and


FDA Issues Interim Safety and Risk Assessment of Melamine and Melamine-related Compounds in Food
The U.S. Food and Drug Administration (FDA) today issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
 

©2006 FDA-News.com. All rights reserved.